In recent developments, Anavex announced promising results from an extension study of their investigational drug, Anavex 2-73 (blarcamesine), for treating Parkinson’s disease dementia. The study revealed that the therapy significantly reduced symptom severity over a one-year period. The extension study followed a Phase 2 clinical trial, known as ANAVEX 2-73-PDD-001, […]
Dr. Alejandro Betancourt is not only a skilled neurosurgeon but also a dedicated advocate for community health education in the Rio Grande Valley. His commitment to raising awareness about neurological health and providing valu able information to the public has made a significant impact on the community. Dr. Betancourt’s medical […]
In a world inundated with synthetic solutions and chemical-laden products, the demand for natural alternatives that promote holistic well-being continues to rise. Enter doTERRA, a trailblazer in the realm of natural health and wellness, offering a comprehensive range of products crafted from the purest essential oils and botanical extracts. Let’s […]
Anavex Life Sciences, a leading biopharmaceutical company, is making significant strides in the field of neurological research. With its innovative approach and commitment to developing groundbreaking therapies, Anavex is at the forefront of addressing unmet medical needs in neurological disorders. Anavex Life Sciences focuses on developing novel drug candidates that […]